n-(2-hydroxypropyl)methacrylamide has been researched along with Disease Models, Animal in 4 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (50.00) | 29.6817 |
2010's | 2 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Carcenac, C; Cottet, C; Fort, S; Pignot-Paintrand, I; Savasta, M; Woerly, S | 1 |
Briggs, SS; Fisher, K; Green, N; Kehoe, S; Morrison, J; Seymour, LW; Subr, V; Ulbrich, K | 1 |
Fábry, M; Janoušková, O; Kovář, M; Král, V; Pechar, M; Pola, R; Sieglová, I; Tomalová, B | 1 |
David, A; Golan, M; Shamay, Y; Tyomkin, D | 1 |
4 other study(ies) available for n-(2-hydroxypropyl)methacrylamide and Disease Models, Animal
Article | Year |
---|---|
Development of a sialic acid-containing hydrogel of poly[N-(2-hydroxypropyl) methacrylamide]: characterization and implantation study.
Topics: Animals; Antibodies, Monoclonal; Axons; Biocompatible Materials; Corpus Striatum; Disease Models, Animal; Dopamine; Fluorescence; G(M3) Ganglioside; Hydrogels; Immunohistochemistry; Implants, Experimental; Materials Testing; Microscopy, Confocal; Microscopy, Electron, Scanning; Oligosaccharides; Oxidopamine; Particle Size; Plant Lectins; Polymethacrylic Acids; Rats; Surface Properties; Temperature; Time Factors; Wheat Germ Agglutinins | 2008 |
Virotherapy of ovarian cancer with polymer-cloaked adenovirus retargeted to the epidermal growth factor receptor.
Topics: Adenoviridae; Animals; Cell Line, Tumor; Disease Models, Animal; Epidermal Growth Factor; ErbB Receptors; Female; Genetic Therapy; Genetic Vectors; Humans; Mice; Oncolytic Virotherapy; Ovarian Neoplasms; Polymers; Polymethacrylic Acids | 2008 |
Polymer Cancerostatics Targeted with an Antibody Fragment Bound via a Coiled Coil Motif: In Vivo Therapeutic Efficacy against Murine BCL1 Leukemia.
Topics: Acrylamides; Animals; Antibodies, Monoclonal; Click Chemistry; Cyclin D1; Disease Models, Animal; Drug Carriers; Drug Delivery Systems; Humans; Immunoconjugates; Immunoglobulin Fragments; Leukemia; Mice; Molecular Targeted Therapy; Peptides; Polymers | 2018 |
Assessing the therapeutic efficacy of VEGFR-1-targeted polymer drug conjugates in mouse tumor models.
Topics: Acrylamides; Animals; Antibiotics, Antineoplastic; Carcinoma, Lewis Lung; Cell Line; Cell Survival; Disease Models, Animal; Doxorubicin; Drug Carriers; E-Selectin; HT29 Cells; Humans; Melanoma, Experimental; Mice, Inbred C57BL; Skin Neoplasms; Treatment Outcome; Tumor Burden; Vascular Endothelial Growth Factor Receptor-1 | 2016 |